Survival and functional status still lagged those of patients with out-of-hospital onset.

Antibody-based therapies currently hold most promise for first wave of effective and widely applicable COVID-19 treatments and prophylaxis.

Co-morbid patients with COVID-19 who became acutely ill shortly after symptom onset were at higher risk of complications and death, despite antiviral therapy.

Population-based study of Generation R, a multi-ethnic cohort followed from foetal life onward.

Semi-automatic phone triage underestimated urgency in 27 per cent of patients with acute coronary syndrome, say researchers.

The babies’ brain responses were not only dampened in the skin-to-skin group but also followed a different neural pathway.

The latest stories you need to know.

Convalescent blood plasma has long been used as a therapy against serious diseases, including the Spanish flu, and will likely be used in future pandemics.

Data from Public Health Scotland for 2019-2020.

The data suggest that self-reported symptoms substantially overestimate COVID-19 disease relative to serology.

Screening all comers age 65+ does not add to detection rates.

Clinicians are doing more of what was already known to be effective.

'Vaccine nationalism’ will prolong pandemic, warns WHO Director General.

Two-thirds of colorectal cancer patients surveyed said they did not receive any nutritional advice or support from their health care team.